Secondary and tertiary sulfonamides: a patent review (2008 – 2012)

Author： Scozzafava Andrea   Carta Fabrizio   Supuran Claudiu T  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.23, Iss.2, 2013-02, pp. : 203-213

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sulfonamides: a patent review (2008 – 2012)

By Carta Fabrizio   Scozzafava Andrea   Supuran Claudiu T  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 7, 2012-07 ,pp. : 747-758

Informa Healthcare

Access to resources Recommend Favorite

Glycogen phosphorylase inhibitors: a patent review (2008 - 2012)

By Gaboriaud-Kolar Nicolas   Skaltsounis Alexios-Leandros  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 8, 2013-08 ,pp. : 1017-1032

Informa Healthcare

Access to resources Recommend Favorite

AT1 antagonists: a patent review (2008 – 2012)

By Mavromoustakos Thomas   Agelis George   Durdagi Serdar  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 11, 2013-11 ,pp. : 1483-1494

Informa Healthcare

Access to resources Recommend Favorite

Osteoclast differentiation inhibitors: a patent review (2008 – 2012)

By Kim Seong Hwan   Moon Seong-Hee  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 12, 2013-12 ,pp. : 1591-1610

Informa Healthcare

Access to resources Recommend Favorite

Indoleamine 2,3-dioxygenase inhibitors: a patent review (2008 – 2012)

By Dolušić Eduard   Frédérick Raphaël  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 10, 2013-10 ,pp. : 1367-1381

Informa Healthcare

Access to resources Recommend Favorite